C1 Fund Inc. (CFND) director reports open-market purchase of 1,693 shares
Rhea-AI Filing Summary
C1 Fund Inc. director reports open-market share purchase
A director of C1 Fund Inc. (CFND), filing individually, reported buying 1,693 shares of common stock in an open-market transaction on 11/21/2025. The transaction was coded as a purchase at a price of $5.91 per share. Following this trade, the director beneficially owns 1,693 common shares, held directly. No derivative securities were reported in this filing.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 1,693 | $5.91 | $10K |
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did C1 Fund Inc. (CFND) disclose?
A director of C1 Fund Inc. disclosed an open-market purchase of 1,693 shares of common stock on 11/21/2025.
What is the relationship of the reporting person to C1 Fund Inc. (CFND)?
The reporting person is identified as a director of C1 Fund Inc. and filed the form as a single reporting person.
Does this C1 Fund Inc. (CFND) Form 4 report any derivative securities?
No. Table II shows no derivative securities acquired, disposed of, or beneficially owned in this filing.
Was the C1 Fund Inc. (CFND) trade filed under a Rule 10b5-1 plan?
The form includes a checkbox for trades under a Rule 10b5-1(c) plan, but the excerpt does not indicate that this box was selected.